Drug maker paid for “news” story on CBS’s 60 Minutes, doctors’ group alleges

Enlarge / A broken watch. (credit: Getty | Carlos Garcia Granthon/Fotoholica Press)

A 13-minute segment on a recent episode of CBS’s 60 Minutes appeared to be a news story on Novo Nordisk’s weight-loss drug Wegovy, but was actually a sponsored promotion violating federal regulations, according to the nonprofit public health advocacy organization Physicians Committee.

The group filed a complaint with the Food and Drug Administration last week, arguing that the segment, which aired on January 1, violates the FDA’s “fair balance” requirement. This law requires that drug advertisements give a fair balance to a drug’s risks and benefits.

The Physicians Committee claims that CBS’s 60 Minutes received advertising payments from Novo Nordisk prior to the coverage, and that the aired segment only included experts who had also been paid by Novo Nordisk. The segment lauded the drug with words and phrases such as “highly effective,” “safe,” “impressive,” “fabulous,” and “robust,” but didn’t delve into side effects or alternative treatments and strategies for weight loss.

Read 3 remaining paragraphs | Comments

Author: Beth Mole. [Source Link (*), Ars Technica – All content]

Shop with us!